The GARDP Foundation (known as GARDP) and the privately-owned, global biopharmaceutical company Debiopharm today announced ...

Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, announced plans ...

Fedora Pharmaceuticals, Inc., a leader in the development of drugs to treat antibiotic-resistant infections, announced plans to unveil the company’s lead candidate at the upcoming Interdisciplinary ...

The Infection Control Academy of India has urged Finance Minister Nirmala Sitharaman to adopt a progressive GST on antibiotics. Access drugs would remain cheap, while Watch and Reserve antibiotics ...

Bacterial Conjunctivitis Drugs Market is expected to reach US$ 4.9 Billion by 2036, Driven by Increasing Prevalence of Eye ...

A team of researchers has demonstrated how advanced robotics combined with click chemistry can dramatically accelerate the ...

While resistance is a natural evolutionary process, the review shows that human activity has dramatically intensified its ...

The GARDP Foundation and Debiopharm have entered a collaboration and license agreement to pursue the development of a novel, first-in-class antibiotic targeting Neisseria gonorrhoeae.

Scientists have discovered a dangerous new gene that makes a Victorian-era disease resistant to strong antibiotics. The ...

Explore the urgent need for proactive infection prevention in Indian hospitals to combat hospital-acquired infections (HAIs).

Callan JMB Inc. (NASDAQ: CJMB), ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, ...

A healthcare expert from the city wanted the Union Finance Minister Nirmala Sitharaman to impose increased GST on the ...